Drug pH-sensitive release in vitro and targeting ability of polyamidoamine dendrimer complexes for tumor cells

Chemical and Pharmaceutical Bulletin

Volumn 59, Issue 1, 2011, Pages 63-71

  Liu, Dan ^a   Hu, Haiyang ^a   Zhang, Jie ^a   Zhao, Xiuli ^a   Tang, Xing ^a   Chen, Dawei ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Antitumor efficacy; Complex; Cytotoxicity; Doxorubicin; pH sensitivity; Polyamidoamine dendrimer

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; DENDRIMER; DOXORUBICIN; LACTOSE; LACTOSE POLY(ETHYLENE GLYCOL) POLY(METHACRYLOYL SULFADIMETHOXINE); MACROGOL; PHOSPHATE BUFFERED SALINE; POLY(ETHYLENE GLYCOL) POLY(METHACRY LOYL SULFADIMETHOXINE); POLYAMIDOAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL STRAIN HEPG2; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DOSAGE FORM COMPARISON; DRUG RELEASE; DRUG TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CANCER; MOUSE; NONHUMAN; PH; PKA; TUMOR CELL;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; DENDRIMERS; DOXORUBICIN; HEP G2 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; LACTOSE; LIVER NEOPLASMS; POLYETHYLENE GLYCOLS; SULFADIMETHOXINE;

EID: 78650803542     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.59.63     Document Type: Article

References (42)

1. Anil K. P., István J. M., James R. B. J., Curr. Opin. Chem. Biol., 6, 466-471 (2002).
2. Stiriba S. E., Privdoz H. F., Haag R., Int. Ed. Engl., 41, 1329-1334 (2002).
3. Aulenta F., Hayes W., Rannard S., Eur. Polym. J., 39, 1741-1771 (2003).
4. Boas U., Heegaard P. M. H., Chem. Soc. Rev., 33, 43-63 (2004).
5. Svenson S., Tomalia D. A., Adv. Drug Deliv. Rev., 57, 2106-2129 (2005).
6. Durairaj C., Ramakrishna S., Farhan J. A., Roop K. K,, Prakash V. D., Biomaterials, 28, 504-512 (2007).
7. Bhadra D., Bhadra S., Jain N. K., Jain A., Int. J. Pharmaceut., 257, 111-124 (2003).
8. Kolhe P., Misra E., Kannan R. M., Kannan S., Lieh-Lai M., Int. J. Pharmaceut., 259, 143-160 (2003).
9. Kannan S., Kolhe P., Raykova V., Glibatec M., Kannan R. M., Lieh-Lai M., Bassett D., J. Biomater. Sci. Polym. Ed., 15, 311-330 (2004).
10. Lee E. S., Gao Z. G., Bae Y. H., J. Controlled Release, 132, 164-170 (2008).
11. Xu H., Deng Y. H., Chen D. W., Wu H. B., Lu Y., J. Controlled Release, 130, 238-245 (2008).
12. Sung W. H., Won H. J., Polymer, 49, 4180-4187 (2008).
13. Taluja A., Bae Y. H., Int. J. Pharmaceut., 358, 50-59 (2008).
14. Han S. K., Na K., Bae Y. H., Colloids Surf. A Physicochem. Eng. Aspects, 214, 49-59 (2003).
15. Wakebayashi D., Nishiyama N., Yamasaki Y., Itaka K., J. Controlled Release, 95, 653-664 (2004).
16. Fallon R. J., Schwartz A. L., Adv. Drug Deliv. Rev., 4, 49-63 (1989).
17. Donati I., Gamini A., Vetere A., Campa C., Paoletti S., Biomacromolecules, 3, 805-812 (2002).
18. Wu J., Nantz M. H., Zern M. A., Front Biosci., 7, 17-25 (2002).
19. Chung T. W., Yang J., Akaike T., et al., Biomaterials, 23, 2827-2834 (2002).
20. Wu D. Q., Lua B., Chang C., Chen C. S., Wang T., Zhang Y. Y., Cheng S. X., Jiang X. J., Zhang X. Z., Zhuo R. X., Biomaterials, 30, 1363-1371 (2009).
21. Kim Y. K., Choi J. Y., Jiang H. L., Arote R., Jere D., Cho M. H., Je Y. H., Cho C. S., Virology, 387, 89-97 (2009).
22. Bao F. S., Wei Z., Rong P., Jie H., Ting H., Colloids Surf. B Biointerfaces, 70, 181-186 (2009).
23. Feng Z. Q., Chu X., Huang N. P., Wang T., Wang Y., Shi X., Ding Y., Gu Z. Z., Biomaterials, 30, 2753-2763 (2009).
24. Muller R. H., Mader K., Gohla S., J. Pharm. Biopharm., 50, 161-177 (2000).
25. Esfand R., Tomalia D. A., Drug Discov. Today, 6, 427-436 (2001).
26. Kojima C., Kono M., Maruyama K., Takagishi T., Bioconjugate Chem., 11, 910-917 (2000).
27. D'Emanuele A., Attwood D., Adv. Drug Deliv. Rev., 57, 2147-2162 (2005).
28. Papagiannaros A., Dimas K., Papaioannou G. T., Demetzos C., Int. J. Pharmaceut., 302, 29-38 (2005).
29. Kurtoglu Y. E., Mishra M. K., Kannan S., Kannan R. M., Int. J. Pharmaceut., 384, 89-194 (2010).
30. Park I. K., Park Y. H., Shin B. A., Choi E. S., Kim Y. R., Akaike T., Cho C. S., J. Controlled Release, 69, 97-108 (2000).
31. Hashida M., Nishikawa M., Yamashita F., Adv. Drug Deliv. Rev., 52, 187-196 (2001).
32. Gao S. Y., Chen J. N., Xu X. R., Ding Z., Yang Y. H., Int. J. Pharmaceut., 255, 57-68 (2003).
33. Sethuraman V. A., Bae Y. H., J. Controlled Release, 118, 216-224 (2007).
34. Holland J. W., Hui C., Cullis P. R., Biochemistry, 35, 2618-2624 (1996).
35. Kirpotin D., Hong K., Mullah N., Papahadjopoulos D., Zalipsky S., FEBS Lett., 388, 115-118 (1996).
36. Drummond D. D., Zignani M., Leroux J. C., Prog. Lipid Res., 39, 409-460 (2000).
37. Mukherjee S., Ghosh R. N., Maxfield F. R., Physiol. Rev., 77, 760-803 (1997).
38. Huang M., Ma Z., Khor E., Lim L. Y., Pharm. Res., 19, 1488-1494 (2002).
39. Goncalves C., Mennesson E., Fuchs R., Gorvel J. P., Midoux P., Pichon C., Mol. Ther., 10, 373-385 (2004).
40. Vandamme T. F., Brobeck L., J. Controlled Release, 102, 23-38 (2005).
41. Schwartz A. L., Fridovich S. E., Knowles B. B., Lodish H. F., J. Biol. Chem., 256, 8878-8881 (1981).
42. Wang Q., Zhang L., Hu W., Bei Y. Y., Xu J. Y., Wang W. J., Zhang X. N., Zhang Q., Nanomedicine: Nanotechnology, Biology, and Medicine, 6, 371-381 (2010).